When taking a closer dive into the world of cannabinoids, we see that the endocannabinoid system plays a major role in the metabolization and interaction of CBD with the body. The ECS is sort of like a highway with various lanes that all lead to different destinations and has neuromodulating functions. Neuromodulation leads to changes in cognitive and emotional changes. In ASD patients, there are observable changes to the ECS system which often times can manifest into seizures, anxiety, irregular sleep patterns, and more. The ECS consists of various enzymes, endocannabinoids, and receptors. One of the main endocannabinoids, anandamide (the bliss molecule), presents itself in lower concentrations in those with ASD. This could very well point to a correlation between low anandamide levels and a presentation of ASD. Another study demonstrated that there was a link between anandamide functions/levels with that of oxytocin. Oxytocin is known as the love hormone responsible for social bonding, feelings of love/warmth, birth labor contractions, breastfeeding and much more. Oxytocin is also released in positive social situations which plays a role in the brain’s perception of social reward. Without oxytocin, anandamide cannot induce social reward and if anandamide levels are too low, then social reward also becomes obsolete. This also supports the idea that administering oxytocin intranasally could be one part of the treatment.